Atrophy rates accelerate in amnestic mild cognitive impairment.
about
The clinical use of structural MRI in Alzheimer diseaseBrain imaging in Alzheimer diseaseEye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's diseaseUshering in the study and treatment of preclinical Alzheimer diseaseTracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersNeuroanatomical substrates of age-related cognitive declineCognitive correlates of cross-sectional differences and longitudinal changes in trail making performanceSpatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data.Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models.The common dementias: a pictorial review.Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Event time analysis of longitudinal neuroimage data.Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.Brain imaging in dementia.Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.Progression of atrophy in Alzheimer's disease and related disorders.Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohortRelationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 yearsSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansPrediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classificationRates of decline in Alzheimer disease decrease with age.A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.Nonlinear time course of brain volume loss in cognitively normal and impaired eldersStudying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometryMapping ventricular expansion onto cortical gray matter in older adults.Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.Early diagnosis of Alzheimer's disease: is MCI too late?Emerging biomarkers in cognition.The dynamics of cortical and hippocampal atrophy in Alzheimer disease.Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.
P2860
Q24609648-71A6E5EE-650D-439B-AF3E-EC488B30F3D7Q26996299-283E3926-15A2-4DC4-A6BA-225B1A7A71C7Q27009241-11E22990-17C8-4296-B8A3-1B808DBB21CFQ27014791-AB7C6343-ACE6-474B-AA6A-F7AB8515B9DCQ29620245-6152D28F-01B1-4E1D-BE5C-7A07A732A795Q30425315-6B5EA75D-86DE-46F8-9AF6-0C2497921226Q30428566-4C8CBB98-C1BB-467D-B464-F5D411AC36BFQ30486156-552FD35F-09CD-4546-8AF9-5FFD21EEC46EQ30576007-427370F4-787A-4CBE-85A4-5E7066DE27B3Q30670885-5830E7BC-750A-4680-9909-0D33996B52CBQ30765803-DD20398A-A514-438F-9B8C-96426C118ABCQ30801659-4B312B6E-9520-45DA-9946-2EA95DFC24A0Q30996675-F9CE503A-B9BB-476D-930E-8336125FFFBDQ31051218-94A34D59-1520-46FA-88E2-9C1A7173B13BQ33540910-E44DA8F2-C8C6-4D89-8C74-5AF46F3B6EECQ33547491-DBFF771F-C938-4AD3-934E-CF72D382A312Q33556006-29FD1D67-0294-4B48-A172-6A4BDFFC42D7Q33652639-BFF8AC8A-8A74-4594-BA42-505490BDDBBCQ33687554-5DCE21E1-0646-41C6-A1A5-FB73D84A31BFQ33689474-1CE33595-76A7-4333-BDE5-E204F724DFE8Q33729033-8F13AC91-40A7-44C4-B96D-ACAA08F53464Q33841363-707C6DA9-F76C-4443-A150-1AFCCCFB2740Q33987747-BA822C48-C675-470D-926D-553A1D3F8AEDQ33996059-D844937F-2D0E-4CC2-B43E-3538660C083FQ34039952-0CEDE0EC-8EF6-40D9-8344-C9DCE748D894Q34052882-48B1EC53-EFBC-461B-962C-1BD9A00F6D71Q34081087-511743DC-A5AF-4F96-8080-50A6BDD2E140Q34183016-6E00A7CC-A896-4283-AA9D-A568D1B180FCQ34372593-DA3AC3D9-E98C-4E52-A372-476CAB91DBB9Q34469900-65B08312-88EC-47C2-95A7-8DB2CF2905E5Q34473063-0EA3EADB-2617-4F51-82F1-C0FCFE7413E0Q34544193-566D2166-DE4D-416A-BC17-37198D48649BQ34615211-3CB65D2D-2607-4B84-9FD6-1B243ABB8D49Q34714892-C92372F1-8322-4628-B39C-23DA2450D646Q34746717-0B318FE5-5A76-4953-B209-E2D3946BC2E7Q34754658-85B39801-73E9-4CC4-A240-592609679DE9Q34992855-500A6179-C421-4209-9E40-E75E17EC80DDQ35008258-B9A5E9B8-3C06-44EA-A852-C272466F12EDQ35643088-4FA86273-C80C-4DCB-8F3F-E7696F4AA192Q35738877-E41A720F-7BB8-4F8C-88E1-1DE5090CD8CB
P2860
Atrophy rates accelerate in amnestic mild cognitive impairment.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Atrophy rates accelerate in amnestic mild cognitive impairment.
@ast
Atrophy rates accelerate in amnestic mild cognitive impairment.
@en
type
label
Atrophy rates accelerate in amnestic mild cognitive impairment.
@ast
Atrophy rates accelerate in amnestic mild cognitive impairment.
@en
prefLabel
Atrophy rates accelerate in amnestic mild cognitive impairment.
@ast
Atrophy rates accelerate in amnestic mild cognitive impairment.
@en
P2093
P2860
P1433
P1476
Atrophy rates accelerate in amnestic mild cognitive impairment.
@en
P2093
D S Knopman
J L Gunter
M M Shiung
P C O'Brien
R C Petersen
S A Przybelski
S D Weigand
P2860
P304
P356
10.1212/01.WNL.0000281688.77598.35
P407
P433
P577
2007-11-21T00:00:00Z